Published in Cell Tissue Kinet on September 01, 1983
Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med (1997) 4.57
Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature (1996) 3.83
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09
Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid) N Engl J Med (1993) 3.06
Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol (1989) 2.77
Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis. Proc Natl Acad Sci U S A (1975) 2.75
Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (1989) 2.63
Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet (1997) 2.48
Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med (1993) 2.15
A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol (1992) 2.11
Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet (1998) 2.09
Comparison of CD271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. J Invest Dermatol (1993) 2.07
Pruritus associated with nocturnal wakenings: organic or psychogenic? J Am Acad Dermatol (1989) 2.06
Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol (2000) 1.97
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet (2000) 1.86
The genetics of psoriasis. Arch Dermatol (1994) 1.84
Psoralen plus black light inhibits epidermal DNA synthesis. Arch Dermatol (1973) 1.75
Molecular mechanisms of retinoid actions in skin. FASEB J (1996) 1.69
Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N Engl J Med (1990) 1.68
Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial. J Rheumatol (1995) 1.68
Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study. JAMA (1988) 1.65
Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol (1995) 1.60
Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment. Nat Med (1999) 1.56
Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest (1998) 1.55
Sulfasalazine improves psoriasis. A double-blind analysis. Arch Dermatol (1990) 1.53
Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol (1991) 1.52
A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia. Arch Dermatol (1989) 1.51
Cyclosporine in dermatology. J Am Acad Dermatol (1989) 1.50
c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest (2000) 1.50
Molecular mechanisms of nonablative fractionated laser resurfacing. Br J Dermatol (2010) 1.47
The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease. Br J Dermatol (2013) 1.44
Bulimia nervosa and acne may be related: a case report. Can J Psychiatry (1992) 1.44
Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo. J Investig Dermatol Symp Proc (1998) 1.43
Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol (2001) 1.42
Cyclosporine in the treatment of psoriatic arthritis. Arch Dermatol (1989) 1.41
Stratification, specialization, and proliferation of primary keratinocyte cultures. Evidence of a functioning in vitro epidermal cell system. J Cell Biol (1978) 1.40
Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy. Arch Dermatol (1995) 1.40
Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol (1994) 1.39
Sulfasalazine: a potential psoriasis therapy? J Am Acad Dermatol (1989) 1.39
IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. J Immunol (1990) 1.39
Lymphocytic infiltrates of the skin in association with cyclosporine therapy. J Am Acad Dermatol (1990) 1.39
Clinical improvement following dermabrasion of photoaged skin correlates with synthesis of collagen I. Arch Dermatol (1994) 1.36
Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol (1990) 1.33
Pemphigoid and pemphigus antigens in cultured epidermal cells. Br J Dermatol (1978) 1.32
Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes. Br J Dermatol (1985) 1.29
All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair. Adult skin from sun-protected and sun-exposed sites responds in an identical manner to RA while neonatal foreskin responds differently. J Clin Invest (1994) 1.28
Cyclic AMP, cyclic GMP, and glucocorticoids as potential metabolic regulators of epidermal proliferation and differentiation. J Invest Dermatol (1975) 1.27
Retinoic acid receptor gene expression in human skin. J Invest Dermatol (1991) 1.27
Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions. Br J Dermatol (1989) 1.26
Retinoic acid and synthetic analogs differentially activate retinoic acid receptor dependent transcription. Biochem Biophys Res Commun (1990) 1.26
Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7. J Biol Chem (2001) 1.24
Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo. Int J Oncol (2001) 1.23
Retinoid therapy is associated with excess granulation tissue responses. J Am Acad Dermatol (1983) 1.23
Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol (1983) 1.22
Psoriasis, T cells and autoimmunity. J R Soc Med (1996) 1.19
Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. Hum Hered (1995) 1.17
Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells. J Invest Dermatol (1989) 1.17
Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A. Arch Dermatol Res (1989) 1.15
Spider bites. Arch Dermatol (1987) 1.15
Increased calmodulin levels in psoriasis and low Ca++ regulated mouse epidermal keratinocyte cultures. J Invest Dermatol (1985) 1.15
Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol (1988) 1.15
Arachidonic acid transformations in normal and psoriatic skin. J Invest Dermatol (1979) 1.14
The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol (2001) 1.14
The metabolism of "histidine-rich" protein in normal and psoriatic keratinization. J Invest Dermatol (1968) 1.14
Anterior segment abnormalities in cicatricial retinopathy of prematurity. Ophthalmology (1979) 1.13
Effects of all-trans retinoic acid and Ca++ on human skin in organ culture. Am J Pathol (1993) 1.12
Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol (1993) 1.12
Identification of heparin-binding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors. EMBO J (1999) 1.11
Differential modulation of keratinocyte intercellular adhesion molecule-I expression by gamma interferon and phorbol ester: evidence for involvement of protein kinase C signal transduction. Br J Dermatol (1990) 1.11
Cyclic nucleotide metabolism in normal and proliferating epidermis. Adv Cyclic Nucleotide Res (1974) 1.11
Development and characterization of a tissue-engineered human oral mucosa equivalent produced in a serum-free culture system. J Dent Res (2000) 1.11
1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol Endocrinol (1999) 1.11
Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells. J Invest Dermatol (1991) 1.09
Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol (1992) 1.09
Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J Clin Invest (1992) 1.09
Differential effects of cAMP and cGMP on in vitro epidermal cell growth. Exp Cell Res (1979) 1.08
Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). Retinoic acid-induced expression of CRABP-II but not CRABP-I in adult human skin in vivo and in skin fibroblasts in vitro. J Biol Chem (1991) 1.08
Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes. Cancer Res (2000) 1.06
Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade. A defective chalone mechanism? Arch Dermatol (1971) 1.06
Glucocorticoid in inflammatory proliferative skin disease reduces arachidonic and hydroxyeicosatetraenoic acids. Science (1977) 1.05
A method for bioassay of an epidermal chalone-like inhibitor. J Invest Dermatol (1971) 1.05
Zinc therapy and distribution in psoriasis. Arch Dermatol (1969) 1.05
Ultraviolet irradiation increases matrix metalloproteinase-8 protein in human skin in vivo. J Invest Dermatol (2001) 1.05
Aryl hydrocarbon hydroxylase, epoxide hydrolase, and benzo[a]-pyrene metabolism in human epidermis: comparative studies in normal subjects and patients with psoriasis. J Invest Dermatol (1984) 1.05
Fatty acid alteration and the lateral diffusion of lipids in the plasma membrane of keratinocytes. Exp Cell Res (1997) 1.04
Gamma interferon induces different keratinocyte cellular patterns of expression of HLA-DR and DQ and intercellular adhesion molecule-I (ICAM-I) antigens. Br J Dermatol (1989) 1.04
T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. J Invest Dermatol (1993) 1.03
Randomized trial comparing cryopreserved cultured epidermal allografts with hydrocolloid dressings in healing chronic venous ulcers. J Am Acad Dermatol (1993) 1.03
Decreased extracellular-signal-regulated kinase and increased stress-activated MAP kinase activities in aged human skin in vivo. J Invest Dermatol (2000) 1.03
All-trans retinoic acid stimulates growth and extracellular matrix production in growth-inhibited cultured human skin fibroblasts. J Invest Dermatol (1990) 1.03
Decreased cyclic AMP in the epidermis of lesions of psoriasis. Arch Dermatol (1972) 1.02
Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol (1990) 1.02
Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects. Arch Dermatol (1986) 1.02
Induction of proliferation of growth-inhibited keratinocytes and fibroblasts in monolayer culture by sodium lauryl sulfate: comparison with all-trans retinoic acid. J Invest Dermatol (1991) 1.01